Clinical Trials Directory

Trials / Completed

CompletedNCT03093363

Impact of a Hospital Pharmacist's Intervention on FENO (Fractional Exhaled Nitric Oxide) in Asthmatic Patients

Study of the Impact of a Hospital Pharmacist's Intervention in Collaboration With Pneumologists on Bronchial Inflammation of Outpatient Asthmatic Patients Seen in University Hospital of Liege

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
68 (actual)
Sponsor
University of Liege · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The impact of a pharmacist's intervention on asthma control has now been well demonstrated, but its effect on inflammatory markers of FENO (Fractional exhaled nitric oxide) in asthmatic patients has been little studied in the literature. The aim of this study is to investigate the impact of a pharmacist's intervention on FENO in patients seen in clinical practice by a pneumologist in a secondary university center.

Conditions

Interventions

TypeNameDescription
OTHERPharmacist's interventionPharmacist's intervention with asthmatic patients: * Detailed questionnaire on asthma and treatments (atopy, comorbidities, smoking status, asthma control, adverse effects of treatments, etc.) * Explanation of asthma and inflammation * Explanation of triggers and how to avoid it * Explanation of asthma treatments * Explanation of the inhalation technique with a physical demonstration * Emphasis on treatment adherence * Assessment of comorbidities and their treatment * Emphasis on influenza vaccination
OTHERQuestionnaires for control group\- Detailed questionnaire on asthma and treatments (atopy, comorbidities, smoking status, asthma control, adverse effects of treatments, etc.)

Timeline

Start date
2016-10-31
Primary completion
2017-04-30
Completion
2017-04-30
First posted
2017-03-28
Last updated
2017-10-25

Source: ClinicalTrials.gov record NCT03093363. Inclusion in this directory is not an endorsement.